SGMO Stock Summary and Trading Ideas (Sangamo Therapeutics | NASDAQ:SGMO)

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its neurology development is focused on two areas: development of epigenetic regulation therapies to treat serious neurological diseases and development of novel engineered adeno-associated virus, or AAV, capsids to deliver its therapies to the intended neurological targets. The group's pipeline products are Small Fiber Neuropathy, Prion Disease, Tauopathies, ALS/FTD, Huntington's Disease, Fabry Disease, and Hemophilia A.

Sangamo Therapeutics trades on the NASDAQ stock market under the symbol SGMO.

As of April 10, 2026, SGMO stock price declined to $0.25 with 4,202,551 million shares trading.

SGMO has a beta of 0.34, meaning it tends to be less sensitive to market movements. SGMO has a correlation of 0.00 to the broad based SPY ETF.

SGMO has a market cap of $93.37 million. This is considered a Micro Cap stock.

Last quarter Sangamo Therapeutics reported $14 million in Revenue and -$.11 earnings per share. This fell short of revenue expectation by $-24 million and missed earnings estimates by -$.09.

In the last 3 years, SGMO traded as high as $3.18 and as low as $.21.

The top ETF exchange traded funds that SGMO belongs to (by Net Assets): VTI, VXF, SCHA, PRFZ, ITOT.

SGMO has underperformed the market in the last year with a price return of -65.3% while the SPY ETF gained +30.9%. SGMO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -43.3% and -21.7%, respectively, while the SPY returned -1.8% and +7.2%, respectively.

SGMO support price is $.24 and resistance is $.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SGMO shares will trade within this expected range on the day.